Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity
Dawei Chen(Shenyang Pharmaceutical University), James W. Welsh(The University of Texas MD Anderson Cancer Center)
Cited by 93
Related Papers
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k
Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases
|JAMA Oncology|2019|226
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
|Radiation Oncology|2009|114
Bone morphogenetic protein 7 promotes resistance to immunotherapy
|Nature Communications|2020|58
Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade
|Journal for ImmunoTherapy of Cancer|2023|26